How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Stocks slide as semiconductor selloff deepens on AI spending fears, valuations, oil tensions and key data ahead.

Explore 100 Mandela Effects so strong you'll question your memory. From movie quotes to logos, discover collective false ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Oppenheimer says SpaceX/Tesla’s Terafab using Intel 18A is critical to SpaceX valuation—AI & space-hardened chips, $120B risk ...

Follow this tag to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings by Tiago Ventura by Chad de Guzman by Chad de Guzman by Callum Sutherland by ...

The twice-yearly ritual has roots in cost-cutting strategies of the late 19th century. A recent effort to end it has stalled in Congress. By Alan Yuhas Hello. You may be here to learn when daylight ...

Complexity is the property of a system whose behaviour as a whole emerges as distinct from the simple sum of its individual behaviours. The understanding of complex systems is therefore beyond the ...

Cathie Wood's ARK Invest bought $2.1M of CoreWeave stock after a 30% crash. Here's why she's betting on the AI cloud company ...